FOR IMMEDIATE RELEASE
January 8, 2026 Ann Arbor, MI
Ann Arbor, Michigan – January 8, 2024 –Genomenon, Inc., a genomic intelligence company, announced that it will be participating in BIO Partnering™ @JPM Week 2026, which takes place from January 12th to January 15th in San Francisco, California.
Details of the event are as follows:
Event: BIO Partnering @JPM Week
Date: January 12-15, 2026
Registration: https://www.bio.org/events/bio-partnering-jpm/registration
Genomenon executives will be available to conduct one-on-one meetings with registered pharmaceutical companies and investors. They are looking to raise awareness within cancer and genetic disease therapeutics regarding the hidden costs caused by a lack of access to comprehensive genomic information at every phase of a drug program.
Schedule your meeting with the Genomenon’s leadership team by connecting with one of our team members through the BIO Partnering system.
Genomenon is a leading literature-derived genomic intelligence and real world evidence company supporting pharmaceutical and clinical organizations in rare disease and precision oncology. By combining clinically aware artificial intelligence with deep scientific expertise, Genomenon transforms fragmented biomedical literature into structured, actionable insights that improve diagnosis and accelerate precision therapeutics development. Genomenon’s solutions are trusted by more than 250 clinical diagnostic laboratories and have supported over 75 drug development programs across global pharma teams. Headquartered in Ann Arbor, Michigan, Genomenon operates with a globally distributed team dedicated to saving and improving lives by making biomedical information actionable.
BIO is the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the U.S. and in more than 30 other nations.
BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
For more information, visit www.bio.org
